Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review

Navari, RM

Navari, RM (reprint author), Univ Alabama Birmingham, Div Hematol Oncol, 1802 6th Ave South,2540K,North Pavil, Birmingham, AL 35294 USA.

EXPERT OPINION ON DRUG SAFETY, 0; ():

Abstract

Objectives: HTX-019 (Cinvanti (R)) is a novel injectable emulsion formulation of the neurokinin 1 receptor antagonist (RA) aprepitant, approved (as 30......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索